Raos, D., Ulamec, M., Katušić Bojanac, A., Bulić Jakuš, F., Ježek, D. & Sinčić, N. (2021). Epigenetically inactivated RASSF1A as a tumor biomarker. Bosnian Journal of Basic Medical Sciences, 21. (4), 386-397. doi: 10.17305/bjbms.2020.5219
Raos, Dora, et al. "Epigenetically inactivated RASSF1A as a tumor biomarker." Bosnian Journal of Basic Medical Sciences, vol. 21, no. 4, 2021, pp. 386-397. https://doi.org/10.17305/bjbms.2020.5219
Raos, Dora, Monika Ulamec, Ana Katušić Bojanac, Floriana Bulić Jakuš, Davor Ježek and Nino Sinčić. "Epigenetically inactivated RASSF1A as a tumor biomarker." Bosnian Journal of Basic Medical Sciences 21, no. 4 (2021): 386-397. https://doi.org/10.17305/bjbms.2020.5219
Raos, D., et al. (2021) 'Epigenetically inactivated RASSF1A as a tumor biomarker', Bosnian Journal of Basic Medical Sciences, 21(4), pp. 386-397. doi: 10.17305/bjbms.2020.5219
Raos D, Ulamec M, Katušić Bojanac A, Bulić Jakuš F, Ježek D, Sinčić N. Epigenetically inactivated RASSF1A as a tumor biomarker. Bosnian Journal of Basic Medical Sciences [Internet]. 2021 August 01 [cited 2024 October 08];21(4):386-397. doi: 10.17305/bjbms.2020.5219
D. Raos, M. Ulamec, A. Katušić Bojanac, F. Bulić Jakuš, D. Ježek and N. Sinčić, "Epigenetically inactivated RASSF1A as a tumor biomarker", Bosnian Journal of Basic Medical Sciences, vol. 21, no. 4, pp. 386-397, August 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:567170. [Accessed: 08 October 2024]